Craig Gordon, pharma analyst
Pharma's Next Big Innovation May Be Affordability

The pharmaceutical industry is a hotbed of innovation. Capital Group investment analyst Craig Gordon, a former practicing physician, discusses the breakthroughs that have him most excited.

August 2017

North American bias, global exposure
Using U.S. Stocks As a Proxy for Global Exposure? Here's What You May Be Missing.

Investors with "North American bias" could be missing out on promising investments abroad.

July 2017

Stephen Green, Andrew Dougherty, China
Inside China's Growth Evolution

China's future growth and economic makeup have serious global implications. Watch as our two China-based pros compare notes from the field.

July 2017

Noriko Chen
Why This Portfolio Manager Sees Her Glass Half Full

Even as global growth slows, there are still opportunities for investors. Capital Group portfolio manager Noriko Chen explains.

July 2017

objective-based investing
Back to the Future: The Return of Objective-Based Investing

A brief history of portfolio construction and insights on the return of objective-based investing.

July 2017


Capital Group Funds (Canada)

Capital Group investment professionals explain the difference between performance and results, and how volatility is part of our equation for long-term results.
Capital Group strives to share economies of scale with investors and keep fees low.